10 results found.

Gastroesophageal Reflux Disease (GERD) Clinical Trial using LINX device

Torax Medical Incorporated - Recruiting 21 years or older.
- A Post-Approval Study of the LINXr Reflux Management System.
LINX device

Esophageal Cancer, Gastroesophageal Reflux Disease, Esophageal Di Clinical Trial using Survey of client health, personal habits, family history; Blood specimen for non-DNA and DNA parts; Biopsy of esophageal/stomach tissue, lymph nodes, tumor; Biopsies from routine clinical surveillance endoscopies

University of Pittsburgh - Recruiting 18 years or older.
- Esophageal Cancer Risk Registry.
Survey of client health, personal habits, family history; Blood specimen for non-DNA and DNA parts; Biopsy of esophageal/stomach tissue, lymph nodes, tumor; Biopsies from routine clinical surveillance endoscopies

Gastroesophageal Reflux Disease, or Hiatal Hernia Clinical Trial using Transoral Incisionless Fundoplication (TIF)

EndoGastric Solutions - Recruiting 18 years to 80 years.
- A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD: the TIF vs. Sham Study.
Transoral Incisionless Fundoplication (TIF)

Gastroesophageal Reflux Disease Clinical Trial using Stretta procedure; Sham procedure

Nantes University Hospital - Recruiting 18 years or older.
- Stretta In Reflux Uncontrolled by Intake of Inhibitors of Protons Pump (IPP).- The SIRUP Trial- Multicentric, Randomized, Double Blind, Prospective Study.
Stretta procedure; Sham procedure

Gastroesophageal Reflux Disease, or Erosive Esophagitis Clinical Trial using Dexlansoprazole; Placebo

Takeda - Recruiting 12 years to 17 years.
- A Phase 2 Multicenter, 36-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn, in Adolescent Subjects Aged 12 to 17 Years.
Dexlansoprazole; Placebo

Gastroesophageal Reflux Disease, or Dyspepsia Clinical Trial using Compound Sodium Alginate Double Action Chewable Tablets; Matching placebo tablets

Reckitt Benckiser Healthcare (UK) Limited - Recruiting 18 years to 65 years.
- A Multi-centre, Randomised, Double-blind, Two Arm, Parallel Group, Placebo-controlled Study to Assess the Effect of Compound Sodium Alginate Double Action Chewable Tablets in Patients With Gastro-esophageal Reflux Disease.
Compound Sodium Alginate Double Action Chewable Tablets; Matching placebo tablets

Gastroesophageal Reflux, or Gastroesophageal Reflux Disease Clinical Trial using PPC-5650; Placebo

Aalborg Universityhospital - Recruiting 20 years to 65 years.
- A Single-center, Randomized, Double-blind, Cross-over Trial in Healthy Volunteers Investigating the Local Efficacy and Safety of a Single Intra-luminal Administration of PPC-5650 on Reflux Pain and Hyperalgesia During Multimodal Stimulation of the Esophagus.
PPC-5650; Placebo

Esophagitis, Reflux Esophagitis, or Gastroesophageal Reflux Disea Clinical Trial using Cessation of Acid Suppressing Medications

Dallas VA Medical Center - Recruiting 18 years or older.
- The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis.
Cessation of Acid Suppressing Medications

Gastroesophageal Reflux Disorder Clinical Trial using Symptom questionnaire

University of South Florida - Recruiting 18 years or older.
- Long and Short Term Outcomes After Laparoscopic Surgery for Gastroesophageal Reflux Disease.
Symptom questionnaire

Gastroesophageal Reflux Clinical Trial using Esomeprazole 20mg once daily

Hospital Authority, Hong Kong - Recruiting 18 years to 80 years.
- The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population.
Esomeprazole 20mg once daily